SEC Form 4 · accession 0001493152-17-014321
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Isaac Simtob
Director
Period of report
Dec 7, 2017
Accepted (ET)
Dec 7, 2017 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2017 | P | 4,100 | $3.95 | A | 45,536 | D | |
| Common Stock | Dec 7, 2017 | P | 100 | $3.97 | A | 45,636 | D | |
| Common Stock | Dec 7, 2017 | P | 800 | $4.00 | A | 46,436 | D | |
| Common StockF1 | holding | — | — | — | 155 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Owned by minor child.